Koyfin Home > Directory > Health Care > Amphastar Pharma > Long-Term Debt / Capital

Amphastar Pharma Long-Term Debt / Capital Chart (AMPH)

Amphastar Pharma annual/quarterly Long-Term Debt / Capital from 2014 to 2018.
  • Amphastar Pharma Long-Term Debt / Capital for the quarter ending December 12, 2018 was $8m a -38.03% decrease of -3m year over year
  • Amphastar Pharma Long-Term Debt / Capital for the last 12 months ending December 12, 2018 was $8m a -38.03% decrease of -3m year over year
  • Amphastar Pharma Annual Long-Term Debt / Capital for 2018 was $8m a -37.69% decrease of -3m from 2017
  • Amphastar Pharma Annual Long-Term Debt / Capital for 2017 was $11m a 17.00% increase of 2m from 2016
  • Amphastar Pharma Annual Long-Term Debt / Capital for 2016 was $9m a -1.64% decrease of 0m from 2015
Other Ratios Metrics:
  • Amphastar Pharma Total Debt / Capital for the quarter ending December 12, 2018 was $12m a -1.34% decrease of 0m year over year
  • Amphastar Pharma Other Liabilities for the quarter ending December 12, 2018 was $10m a -0.42% decrease of 0m year over year
  • Amphastar Pharma Total Debt / Equity for the quarter ending December 12, 2018 was $14m a -1.53% decrease of 0m year over year
View Chart On Koyfin

Quarterly AMPH Long-Term Debt / Capital Data

12/2018$8m
09/2018$8m
06/2018$9m
03/2018$11m
12/2017$11m
09/2017$11m
06/2017$11m
03/2017$9m
12/2016$9m
09/2016$9m

Annual AMPH Long-Term Debt / Capital Data

2018$8m
2017$11m
2016$9m
2015$9m
2014$11m
2013$4m